COMMUNIQUÉS West-GlobeNewswire
-
Retrotope Presents Data Demonstrating Arrest of Disease Progression with Treatment of RT001 in Patients with Infantile Neuroaxonal Dystrophy (INAD)
15/10/2018 - 13:30 -
Theratechnologies Appoints New Board Member
15/10/2018 - 13:30 -
Theratechnologies nomme un nouveau membre à son conseil d’administration
15/10/2018 - 13:30 -
Apotheca Biosciences (PCFP) Announces Addition of Dr. Mali Reddy, Seven Time Nobel Prize Nominee, as Chief Medical Adviser & Medical Researcher
15/10/2018 - 13:30 -
EDAP TMS SA : EDAP Announces Expiration of Tranche of Outstanding Warrants
15/10/2018 - 13:00 -
XORTX Announces New Clinical Advisory Board Members
15/10/2018 - 13:00 -
Athenex and Xiangxue Life Sciences Announce Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy (TAEST) Showed Encouraging Positive Clinical Signals
15/10/2018 - 13:00 -
Aravive Biologics and Versartis Complete Merger
15/10/2018 - 13:00 -
Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292 for the Treatment of RET Fusion-Positive Thyroid Cancer
15/10/2018 - 12:45 -
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
15/10/2018 - 12:30 -
Tetra Bio-Pharma Names Dr. Guy Chamberland as Chief Executive Officer and Chief Scientific Officer
15/10/2018 - 12:30 -
Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm
15/10/2018 - 12:01 -
Hygiene Drive at Doug Disraeli D.D.S. Dental Office Aims to Provide Much Needed Items for Homeless in Uptown San Diego – Goal is to Donate 1000 Toothbrushes
15/10/2018 - 12:00 -
Dynavax Technologies and Quantum Leap Healthcare Collaborative Announce Selection of SD-101 Combined with KEYTRUDA® (pembrolizumab) in the I-SPY 2 TRIAL For Breast Cancer
15/10/2018 - 12:00 -
RavenQuest Launches Recreational Brands, Introduces Eight Unique “Experiences” for the Adult Recreational Consumer
15/10/2018 - 12:00 -
Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend
15/10/2018 - 12:00 -
Zealand grants new warrants under employee warrant program
15/10/2018 - 10:33 -
Orphazyme endorses patient advocacy consensus guidelines, highlights importance of collaboration with patient communities
15/10/2018 - 09:08 -
Chairman of the Board will not seek re-election
15/10/2018 - 08:22
Pages